ArticleTranslational oncology2013

Arsenic Trioxide as a Vascular Disrupting Agent: Synergistic Effect with Irinotecan on Tumor Growth Delay in a CT26 Allograft Model.

Jong Cheol Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.